| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |